Firms such as Cipla, Alembic Pharma and Unichem Laboratories will be impacted by the government’s move for prices fixation and revision
Pharma pricing authority National Pharmaceutical Pricing Authority (NPPA) has capped prices of 18 formulations packs, including anti-diabetic Metformin HCl tablets, antibacterial ceftriaxone sodium injection packs and devices among others.
Prices have also been fixed/revised for hormone releasing IUD, ondansetron HCl orally disintegrating strip, Metformin HCl tablets, Cefaclass injection pack among others.
The prices of the 18 formulation packs have been fixed/ revised under Drug Price Control Order (DPCO), 2013, said NPPA.
Firms such as Cipla, Alembic Pharma and Unichem Laboratories will be impacted by the government’s move for prices fixation and revision.
At present, the government caps prices of essential drugs based on the simple average of all medicines in a particular therapeutic segment with sales of more than one per cent. In case of non-scheduled formulations companies are allowed to hike prices of medicines by only up to 10 per cent in a year. The government had notified DPCO 2013 to cover 680 formulations, effective May 15, 2014.